Oncocross Co., Ltd. (KOSDAQ: A382150)
Health Care · Biotechnology · KR
₩3,700.00
-6.80% today · -58.9% 1Y
Oncocross Co., Ltd. (KOSDAQ: A382150) operates in the Biotechnology industry within the Health Care sector. The company is valued at $34.15M.
Over the last twelve months the share price has lost 58.9%, trading between 2.23K and 14.49K.
Tweenvest scores Oncocross Co., Ltd. across four factors: quality 29/100, value 41/100, growth 73/100. Its strongest factor is growth.
A382150 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $34.15M
- Revenue (TTM)
- $312.15K
- P/E
- —
- EPS
- -773.91
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩14,490.00
- 52-week low
- ₩2,235.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.05M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.93 | +0.53% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $445.06 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.15 | +0.96% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $554.43 | +1.25% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $836.56 | +0.97% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $157.92 | +13.70% |
Figures last refreshed Aug 18, 2026.